DOP2009000266A - Compuestos quimicos - Google Patents
Compuestos quimicosInfo
- Publication number
- DOP2009000266A DOP2009000266A DO2009000266A DO2009000266A DOP2009000266A DO P2009000266 A DOP2009000266 A DO P2009000266A DO 2009000266 A DO2009000266 A DO 2009000266A DO 2009000266 A DO2009000266 A DO 2009000266A DO P2009000266 A DOP2009000266 A DO P2009000266A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- chemical compounds
- compounds
- present
- infection
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Abstract
La presente invencion se refiere a compuestos que son inhibidores de transcriptasa inversa que no son nucleosidos, y a procesos para la preparacion y uso de los mismos. De una manera especifica, la presente invencion incluye metodos papa utilizar tales compuestos en el tratamiento de infeccion por el inmunodeficiencia humana.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94226607P | 2007-06-06 | 2007-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2009000266A true DOP2009000266A (es) | 2010-02-15 |
Family
ID=40130130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2009000266A DOP2009000266A (es) | 2007-06-06 | 2009-11-27 | Compuestos quimicos |
Country Status (25)
Country | Link |
---|---|
US (1) | US8304419B2 (es) |
EP (1) | EP2166856A4 (es) |
JP (1) | JP2010529965A (es) |
KR (1) | KR20100039301A (es) |
CN (1) | CN101790313A (es) |
AR (1) | AR066909A1 (es) |
AU (1) | AU2008261977A1 (es) |
BR (1) | BRPI0812738A2 (es) |
CA (1) | CA2694871A1 (es) |
CL (1) | CL2008001631A1 (es) |
CO (1) | CO6251246A2 (es) |
CR (1) | CR11196A (es) |
DO (1) | DOP2009000266A (es) |
EA (1) | EA017141B1 (es) |
IL (1) | IL202217A0 (es) |
MA (1) | MA31500B1 (es) |
MX (1) | MX2009013349A (es) |
NZ (1) | NZ581409A (es) |
PE (1) | PE20090330A1 (es) |
SG (1) | SG182162A1 (es) |
TW (1) | TW200901969A (es) |
UA (1) | UA98784C2 (es) |
UY (1) | UY31132A1 (es) |
WO (1) | WO2008154271A1 (es) |
ZA (1) | ZA200908604B (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007314521A1 (en) * | 2006-10-06 | 2008-05-08 | Merck Sharp & Dohme Corp. | Non-nucleoside reverse transcriptase inhibitors |
CA2740195A1 (en) | 2008-12-23 | 2010-07-01 | Abbott Laboratories | Anti-viral compounds |
EP2367824B1 (en) * | 2008-12-23 | 2016-03-23 | AbbVie Inc. | Anti-viral derivatives of pyrimidine |
RU2541571C2 (ru) | 2009-04-15 | 2015-02-20 | Эббви Инк. | Противовирусные соединения |
EP2461694A4 (en) | 2009-08-06 | 2013-06-19 | Neuraltus Pharmaceuticals Inc | TREATMENT OF DISORDERS ASSOCIATED WITH MACROPHAGES |
JP5851998B2 (ja) * | 2009-10-27 | 2016-02-03 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | 殺虫剤および殺ダニ剤としてのハロアルキル置換アミド |
RU2608611C2 (ru) | 2009-11-05 | 2017-01-23 | Юниверсити Оф Нотр Дам Дю Лак | СОЕДИНЕНИЯ ИМИДАЗО[1,2-а] ПИРИДИНА, ИХ СИНТЕЗ И СПОСОБЫ ПРИМЕНЕНИЯ |
CA2793086C (en) * | 2010-03-18 | 2018-08-21 | Institut Pasteur Korea | Substituted imidazo[1,2-a]pyridine compounds and their use in the treatment of bacterial infections |
WO2011146817A1 (en) * | 2010-05-21 | 2011-11-24 | Gilead Sciences, Inc. | Heterocyclic flaviviridae virus inhibitors |
US8987307B2 (en) | 2011-03-03 | 2015-03-24 | Hoffmann-La Roche Inc. | 3-amino-pyridines as GPBAR1 agonists |
EP2511263A1 (en) | 2011-04-14 | 2012-10-17 | Phenex Pharmaceuticals AG | Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
MX2014009713A (es) | 2012-04-04 | 2014-09-12 | Hoffmann La Roche | Derivados de 1,2-piridazina, 1,6-piridazina o pirimidina-benzamida como moduladores del receptor de acidos biliares acoplado a la proteina g1 (gpbar1). |
JP6278472B2 (ja) | 2013-02-27 | 2018-02-14 | 塩野義製薬株式会社 | Ampk活性化作用を有するインドールおよびアザインドール誘導体 |
JO3603B1 (ar) * | 2013-05-17 | 2020-07-05 | Janssen Sciences Ireland Uc | مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي |
EP3316969B1 (en) * | 2015-07-02 | 2022-03-02 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
IL257743B (en) | 2015-09-17 | 2022-08-01 | Marvin J Miller | Heterocyclic compounds containing benzyl amine and preparations useful against mycobacterial inflammation |
EP3472158A1 (en) | 2016-06-16 | 2019-04-24 | Janssen Sciences Ireland Unlimited Company | Heterocyclic compounds as antibacterials |
EP3535242B1 (en) | 2016-10-20 | 2024-01-24 | B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University | Dna primase and gyrase inhibitors |
KR20190121315A (ko) | 2017-03-01 | 2019-10-25 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 병용 요법 |
CN109748927A (zh) * | 2017-11-03 | 2019-05-14 | 上海交通大学医学院附属瑞金医院 | 杂芳基酰胺类化合物、其制备方法、药用组合物及其应用 |
JP7013048B2 (ja) * | 2018-03-02 | 2022-01-31 | 国立大学法人大阪大学 | タンパク質及び/又はペプチド修飾用分子 |
US11370758B2 (en) * | 2018-03-23 | 2022-06-28 | Cmg Pharmaceutical Co., Ltd. | IDO-TDO dual inhibitor and related methods of use |
CN111954532A (zh) * | 2018-04-13 | 2020-11-17 | 上海交通大学医学院附属瑞金医院 | 杂芳基酰胺类化合物的抗肿瘤多药耐药性、治疗癌症的用途和蛋白质-药物分子复合物 |
WO2020072580A1 (en) | 2018-10-02 | 2020-04-09 | Disc Medicine, Inc. | Matriptase 2 inhibitors and uses thereof |
US10959987B2 (en) | 2019-04-15 | 2021-03-30 | King Abdulaziz University | Imidazole-based compounds as hepatitis C virus inhibitors |
KR102051783B1 (ko) * | 2019-09-02 | 2019-12-03 | 부산대학교 산학협력단 | 3,10-이치환 벤조풀벤 유도체의 신규 합성방법 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9716446D0 (en) * | 1997-08-05 | 1997-10-08 | Agrevo Uk Ltd | Fungicides |
JP2000256323A (ja) * | 1999-01-08 | 2000-09-19 | Japan Tobacco Inc | 2−オキソキノリン化合物及びその医薬用途 |
DE10161765A1 (de) * | 2001-12-15 | 2003-07-03 | Bayer Cropscience Gmbh | Substituierte Phenylderivate |
WO2004080966A1 (ja) * | 2003-03-14 | 2004-09-23 | Ono Pharmaceutical Co., Ltd. | 含窒素複素環誘導体およびそれらを有効成分とする薬剤 |
UA84020C2 (ru) * | 2003-09-11 | 2008-09-10 | Тиботек Фармасьютикелз Лтд. | Ингибитор проникновения вируса вил |
WO2005026114A1 (en) * | 2003-09-17 | 2005-03-24 | Pfizer Inc. | Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses |
DE602004011985T2 (de) * | 2003-11-25 | 2009-03-05 | Eli Lilly And Co., Indianapolis | Modulatoren des peroxisomproliferatoraktivierten rezeptors |
CN1946680B (zh) * | 2004-04-23 | 2011-04-06 | 弗·哈夫曼-拉罗切有限公司 | 非核苷逆转录酶抑制剂 |
US7166738B2 (en) * | 2004-04-23 | 2007-01-23 | Roche Palo Alto Llc | Non-nucleoside reverse transcriptase inhibitors |
US20060004197A1 (en) * | 2004-07-02 | 2006-01-05 | Thomas Thrash | Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
US20060025480A1 (en) * | 2004-08-02 | 2006-02-02 | Boehringer Ingelheim International Gmbh | Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors |
AR057455A1 (es) * | 2005-07-22 | 2007-12-05 | Merck & Co Inc | Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica |
US7606430B2 (en) * | 2005-08-30 | 2009-10-20 | Asml Netherlands B.V. | Lithographic apparatus and device manufacturing method utilizing a multiple dictionary compression method for FPD |
CN101679294B (zh) * | 2007-05-30 | 2012-08-08 | 弗·哈夫曼-拉罗切有限公司 | 非核苷逆转录酶抑制剂 |
-
2008
- 2008-06-04 TW TW097120769A patent/TW200901969A/zh unknown
- 2008-06-04 CL CL2008001631A patent/CL2008001631A1/es unknown
- 2008-06-05 JP JP2010511315A patent/JP2010529965A/ja active Pending
- 2008-06-05 CA CA2694871A patent/CA2694871A1/en not_active Abandoned
- 2008-06-05 NZ NZ581409A patent/NZ581409A/en not_active IP Right Cessation
- 2008-06-05 SG SG2012041091A patent/SG182162A1/en unknown
- 2008-06-05 UA UAA200911848A patent/UA98784C2/ru unknown
- 2008-06-05 CN CN200880102121A patent/CN101790313A/zh active Pending
- 2008-06-05 PE PE2008000971A patent/PE20090330A1/es not_active Application Discontinuation
- 2008-06-05 WO PCT/US2008/065865 patent/WO2008154271A1/en active Application Filing
- 2008-06-05 US US12/667,581 patent/US8304419B2/en not_active Expired - Fee Related
- 2008-06-05 AU AU2008261977A patent/AU2008261977A1/en not_active Abandoned
- 2008-06-05 EP EP08756713A patent/EP2166856A4/en not_active Withdrawn
- 2008-06-05 EA EA200901490A patent/EA017141B1/ru not_active IP Right Cessation
- 2008-06-05 BR BRPI0812738-7A2A patent/BRPI0812738A2/pt not_active IP Right Cessation
- 2008-06-05 KR KR1020097027635A patent/KR20100039301A/ko not_active Application Discontinuation
- 2008-06-05 MX MX2009013349A patent/MX2009013349A/es not_active Application Discontinuation
- 2008-06-06 UY UY31132A patent/UY31132A1/es not_active Application Discontinuation
- 2008-06-06 AR ARP080102424A patent/AR066909A1/es not_active Application Discontinuation
-
2009
- 2009-11-18 IL IL202217A patent/IL202217A0/en unknown
- 2009-11-27 DO DO2009000266A patent/DOP2009000266A/es unknown
- 2009-12-03 ZA ZA2009/08604A patent/ZA200908604B/en unknown
- 2009-12-09 CO CO09140797A patent/CO6251246A2/es active IP Right Grant
-
2010
- 2010-01-04 MA MA32473A patent/MA31500B1/fr unknown
- 2010-01-06 CR CR11196A patent/CR11196A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR066909A1 (es) | 2009-09-23 |
CN101790313A (zh) | 2010-07-28 |
MX2009013349A (es) | 2010-01-20 |
IL202217A0 (en) | 2010-06-16 |
EA200901490A1 (ru) | 2010-06-30 |
UY31132A1 (es) | 2009-03-31 |
UA98784C2 (ru) | 2012-06-25 |
AU2008261977A1 (en) | 2008-12-18 |
US20100216746A1 (en) | 2010-08-26 |
WO2008154271A1 (en) | 2008-12-18 |
SG182162A1 (en) | 2012-07-30 |
BRPI0812738A2 (pt) | 2014-09-30 |
EP2166856A1 (en) | 2010-03-31 |
US8304419B2 (en) | 2012-11-06 |
MA31500B1 (fr) | 2010-07-01 |
CL2008001631A1 (es) | 2009-01-02 |
CO6251246A2 (es) | 2011-02-21 |
CA2694871A1 (en) | 2008-12-18 |
TW200901969A (en) | 2009-01-16 |
PE20090330A1 (es) | 2009-04-30 |
NZ581409A (en) | 2012-03-30 |
KR20100039301A (ko) | 2010-04-15 |
CR11196A (es) | 2010-03-08 |
EP2166856A4 (en) | 2012-05-30 |
EA017141B1 (ru) | 2012-10-30 |
ZA200908604B (en) | 2011-02-23 |
JP2010529965A (ja) | 2010-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2009000266A (es) | Compuestos quimicos | |
SV2016005257A (es) | Benzimidazol-2-aminas como inhibidores de midh1 | |
CL2011000917A1 (es) | Compuestos derivados de tioamida; sus metodos de preparacion y uso de los compuestos para el tratamiento de enfermedades endoparasitarias. | |
DOP2014000133A (es) | Triazolopiridinas sustituidas | |
ECSP10010112A (es) | Compuestos de tienopirimidina y pirazolopirimidina y su uso como inhibidores de mtor cinasa y pi3 cinasa | |
PA8819201A1 (es) | Derivados de azetidina y ciclobutano como inhibidores de jak | |
GT201400009A (es) | 4-imidazopiridazin-1-il-benzamidas y 4-imidazotriazin-1-il-benzamidas como inhibidores de btk | |
CL2013000063A1 (es) | Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion. | |
GT200600074A (es) | 5-alcoxialquil-6-alquil-7-amino-azolopirimidinas, un procedimiento para su obtención y el uso de las mismas para combatir hongos nocivos, así como procuctos que las mismas contienen | |
CL2011002115A1 (es) | Compuestos derivados de 5-fenil-1h-piridin-2-ona y 5-fenil-pirazin-2-ona, inhibidores de la tirosina-quinasa de bruton (btk); proceso de preparación de los compuestos, compuesto intermediario, composición farmacéutica y uso en el tratamiento de enfermedades inflamatorias y/o autoinmunes. | |
ECSP12012318A (es) | Inhibidores de pirazolil quinazolina cinasa | |
ECSP12011935A (es) | Triazolopiridinas | |
GT200900230A (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso | |
ECSP109903A (es) | Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares | |
ECSP13013011A (es) | Triazolopiridinas | |
UY32611A (es) | Compuestos de 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
CR20120264A (es) | Compuestos | |
DOP2012000312A (es) | Triazolopiridinas sustituidas | |
ECSP088749A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
CL2011001331A1 (es) | Clorhidrato de nalmefeno dihidratado; métodos para su preparación; composición farmacéutica que lo comprende; y uso para el tratamiento del alcoholismo. | |
SV2010003514A (es) | Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas | |
UY31922A (es) | Compuestos | |
CL2009001686A1 (es) | Procedimiento de preparacion de agomelatina; y los compuestos intermediarios considerados. | |
UY31905A (es) | Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
CR20160016A (es) | Pirazolpiridinas sustituidas |